Canaccord Adams assumes coverage on Dolby Laboratories (NYSE: DLB) with a Buy. Price target $40.

Canaccord analyst says, "Dolby is ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE